Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1972 1
1974 6
1975 3
1976 1
1977 1
1978 1
1981 3
1982 3
1983 2
1984 3
1985 2
1986 2
1987 1
1988 3
1989 2
1990 1
1991 1
1992 7
1993 6
1994 8
1995 4
1996 4
1997 1
1998 3
1999 4
2000 6
2001 4
2002 2
2003 3
2004 4
2005 7
2006 5
2007 1
2008 5
2009 4
2010 1
2011 2
2012 1
2013 2
2018 2
2020 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

121 results

Results by year

Filters applied: . Clear all
Page 1
Telmisartan, ramipril, or both in patients at high risk for vascular events.
ONTARGET Investigators; Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C. ONTARGET Investigators, et al. N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317. Epub 2008 Mar 31. N Engl J Med. 2008. PMID: 18378520 Free article. Clinical Trial.
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.
Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators; Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P. Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators, et al. Lancet. 2008 Sep 27;372(9644):1174-83. doi: 10.1016/S0140-6736(08)61242-8. Epub 2008 Aug 29. Lancet. 2008. PMID: 18757085 Clinical Trial.
L'Alimentation Parentérale.
Degaute JP, Cornil JP. Degaute JP, et al. Acta Clin Belg. 1975 Jan;30(1):33-47. doi: 10.1080/17843286.1975.11716972. Acta Clin Belg. 1975. PMID: 27368379
[Stress and arterial hypertension].
Degaute JP. Degaute JP. Rev Med Liege. 1982 Dec;37 Suppl 1:29-32. Rev Med Liege. 1982. PMID: 6130592 Review. French. No abstract available.
[The cardiology department].
Degaute JP, Berkenboom G, Renard M, Stoupel E, Unger P, Vachiery JL, van de Borne P. Degaute JP, et al. Rev Med Brux. 2002;23 Suppl 2:27-9. Rev Med Brux. 2002. PMID: 12584905 Review. French.
[Current therapy: losartan].
Degaute JP, Sternon J. Degaute JP, et al. Rev Med Brux. 1997 Oct;18(5):335-8. Rev Med Brux. 1997. PMID: 9441330 Review. French.
Recommendations for prevention, diagnosis and management of hypertension and cardiovascular risk factors in sub-Saharan Africa.
Lemogoum D, Seedat YK, Mabadeje AF, Mendis S, Bovet P, Onwubere B, Blackett KN, Lenfant C, Kabangu JR, Block P, Belhocine M, Degaute JP; International Forum for Hypertension control and prevention in Africa. Lemogoum D, et al. Among authors: degaute jp. J Hypertens. 2003 Nov;21(11):1993-2000. doi: 10.1097/00004872-200311000-00003. J Hypertens. 2003. PMID: 14597837 Review. No abstract available.
Serial lactate determinations during circulatory shock.
Vincent JL, Dufaye P, Berré J, Leeman M, Degaute JP, Kahn RJ. Vincent JL, et al. Among authors: degaute jp. Crit Care Med. 1983 Jun;11(6):449-51. doi: 10.1097/00003246-198306000-00012. Crit Care Med. 1983. PMID: 6406145
121 results